Código QR (código de barras bidimensional)

Risks Associated with 5α-Reductase Inhibitor Use: Analysis of Adverse Drug Reactions Reported to EudraVigilance

<b>Background/Objectives</b>: 5α-Reductase inhibitors (5ARIs) are commonly used to treat and prevent androgenic alopecia and benign prostatic hyperplasia. Despite their well-established effectiveness, they are associated with adverse drug reactions (ADRs), highlighting the need for continuous safety...

ver descrição completa

Na minha lista:
Principais autores: Ricardo Alves, Samuel Silvestre, Cristina Monteiro
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI AG 2026-06-01
coleção:Pharmaceuticals
Assuntos:
5α-reductase
dutasteride
finasteride
benign prostatic hyperplasia
androgenic alopecia
pharmacovigilance
Acesso em linha:https://www.mdpi.com/1424-8247/19/6/939
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados